|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4002531A
(en)
|
1976-01-22 |
1977-01-11 |
Pierce Chemical Company |
Modifying enzymes with polyethylene glycol and product produced thereby
|
|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
US5770697A
(en)
|
1986-11-04 |
1998-06-23 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
US6018030A
(en)
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
US5641648A
(en)
|
1986-11-04 |
1997-06-24 |
Protein Polymer Technologies, Inc. |
Methods for preparing synthetic repetitive DNA
|
|
US5514581A
(en)
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
|
US4863457A
(en)
|
1986-11-24 |
1989-09-05 |
Lee David A |
Drug delivery device
|
|
US4997652A
(en)
|
1987-12-22 |
1991-03-05 |
Visionex |
Biodegradable ocular implants
|
|
WO1990003430A1
(en)
|
1988-09-23 |
1990-04-05 |
Cetus Corporation |
Cell culture medium for enhanced cell growth, culture longevity and product expression
|
|
CA2053317C
(en)
|
1989-04-19 |
1996-03-12 |
Shmuel Zalipsky |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
FR2646437B1
(fr)
|
1989-04-28 |
1991-08-30 |
Transgene Sa |
Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
|
|
US5164188A
(en)
|
1989-11-22 |
1992-11-17 |
Visionex, Inc. |
Biodegradable ocular implants
|
|
WO1992002536A1
(en)
|
1990-08-02 |
1992-02-20 |
The Regents Of The University Of Colorado |
Systematic polypeptide evolution by reverse translation
|
|
JP3051145B2
(ja)
|
1990-08-28 |
2000-06-12 |
住友製薬株式会社 |
新規なポリエチレングリコール誘導体修飾ペプチド
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
KR0185215B1
(ko)
|
1990-11-30 |
1999-05-01 |
요시다 쇼오지 |
서방성 안구삽입용 약제
|
|
US5773574A
(en)
|
1990-12-03 |
1998-06-30 |
The Scripps Research Institute |
Polypeptides for promoting cell attachment
|
|
US5235041A
(en)
|
1990-12-28 |
1993-08-10 |
Protein Polymer Technologies, Inc. |
Purification of structurally ordered recombinant protein polymers
|
|
US5792742A
(en)
|
1991-06-14 |
1998-08-11 |
New York University |
Fibrin-binding peptide fragments of fibronectin
|
|
AU2313392A
(en)
|
1991-08-01 |
1993-03-02 |
University Research Corporation |
Systematic polypeptide evolution by reverse translation
|
|
NZ255041A
(en)
|
1992-07-13 |
1996-11-26 |
Bionebraska Inc |
Preparation of a recombinant single copy polypeptide or portion thereof modified with a terminal alpha amino carbon reactive group and reactive side chain groups involving biologically added protective groups
|
|
EP0669836B1
(en)
|
1992-11-13 |
1996-07-03 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
|
|
WO1994017097A1
(en)
|
1993-01-19 |
1994-08-04 |
Regents Of The University Of Minnesota |
Synthetic fibronectin fragments as inhibitors of retroviral infections
|
|
WO1994018921A1
(en)
|
1993-02-26 |
1994-09-01 |
Santen Pharmaceutical Co., Ltd. |
Biodegradable sclera plug
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
AU8124694A
(en)
|
1993-10-29 |
1995-05-22 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5516522A
(en)
|
1994-03-14 |
1996-05-14 |
Board Of Supervisors Of Louisiana State University |
Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5559000A
(en)
|
1995-01-18 |
1996-09-24 |
The Scripps Research Institute |
Encoded reaction cassette
|
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US6369116B1
(en)
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
|
DE19646372C1
(de)
|
1995-11-11 |
1997-06-19 |
Evotec Biosystems Gmbh |
Genotyp und Phänotyp koppelnde Verbindung
|
|
GB9618960D0
(en)
|
1996-09-11 |
1996-10-23 |
Medical Science Sys Inc |
Proteases
|
|
US5922676A
(en)
|
1996-09-20 |
1999-07-13 |
The Burnham Institute |
Methods of inhibiting cancer by using superfibronectin
|
|
WO1998016636A1
(en)
|
1996-10-17 |
1998-04-23 |
Mitsubishi Chemical Corporation |
Molecule that homologizes genotype and phenotype and utilization thereof
|
|
WO1998031794A1
(fr)
|
1997-01-17 |
1998-07-23 |
Toa Gosei Co., Ltd. |
Polypeptide liant le facteur vegf
|
|
US6261804B1
(en)
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
|
PT1712623E
(pt)
|
1997-01-21 |
2011-12-21 |
Gen Hospital Corp |
Selecção de proteínas utilizando fusões de arn-proteína
|
|
WO1998048837A1
(en)
*
|
1997-04-30 |
1998-11-05 |
Enzon, Inc. |
Polyalkylene oxide-modified single chain polypeptides
|
|
CA2293632C
(en)
|
1997-06-12 |
2011-11-29 |
Research Corporation Technologies, Inc. |
Artificial antibody polypeptides
|
|
US6159722A
(en)
|
1997-12-03 |
2000-12-12 |
Boehringer Mannheim Gmbh |
Chimeric serine proteases
|
|
CA2323638A1
(en)
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
|
US20030045681A1
(en)
|
1998-05-11 |
2003-03-06 |
Anthony J. Zelano |
Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
|
|
JP4108827B2
(ja)
|
1998-05-28 |
2008-06-25 |
大日本印刷株式会社 |
無機質系化粧板
|
|
CA2342967A1
(en)
|
1998-12-08 |
2000-06-15 |
Biovation Limited |
Modifying protein immunogenicity
|
|
ATE439592T1
(de)
|
1998-12-10 |
2009-08-15 |
Bristol Myers Squibb Co |
Proteingerüste für antikörper-nachahmer und andere bindende proteine
|
|
US7115396B2
(en)
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
US6818418B1
(en)
*
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
GB9827228D0
(en)
|
1998-12-10 |
1999-02-03 |
Univ Nottingham |
Cancer detection method and reagents
|
|
US6416758B1
(en)
|
1999-04-28 |
2002-07-09 |
Board Of Regents, The University Of Texax System |
Antibody conjugate kits for selectively inhibiting VEGF
|
|
DE60034566T2
(de)
|
1999-07-27 |
2008-01-03 |
Adnexus Therapeutics, Inc., Waltham |
Peptidakzeptor ligationsverfahren
|
|
US6399857B1
(en)
|
1999-09-22 |
2002-06-04 |
Paradigm Genetics, Inc. |
Modified nucleotide sequence encoding a LexA DNA binding domain optimized for arabidopsis species
|
|
CA2404528A1
(en)
|
2000-03-31 |
2001-10-04 |
Institut Pasteur |
Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
|
|
US20030104520A1
(en)
|
2000-06-15 |
2003-06-05 |
Ellington Andrew D. |
Regulatable, catalytically active nucleic acids
|
|
JP4578768B2
(ja)
|
2000-07-11 |
2010-11-10 |
リサーチ コーポレイション テクノロジーズ，インコーポレイテッド |
人工抗体ポリペプチド
|
|
EP1324779B1
(en)
|
2000-09-29 |
2011-07-20 |
Schering Corporation |
Pegylated interleukin-10
|
|
AU1325102A
(en)
|
2000-10-16 |
2002-04-29 |
Phylos Inc |
Protein scaffolds for antibody mimics and other binding proteins
|
|
US7598352B2
(en)
|
2000-11-17 |
2009-10-06 |
University Of Rochester |
Method of identifying polypeptide monobodies which bind to target proteins and use thereof
|
|
AU3649502A
(en)
|
2000-11-29 |
2002-06-11 |
Oculex Pharm Inc |
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
|
US6509027B2
(en)
|
2001-02-12 |
2003-01-21 |
Supergen, Inc. |
Injectable pharmaceutical composition comprising coated particles of camptothecin
|
|
WO2002081497A2
(en)
|
2001-04-04 |
2002-10-17 |
University Of Rochester |
αξβ3 INTEGRIN-BINDING POLYPEPTIDE MONOBODIES AND THEIR USE
|
|
AU2002256371B2
(en)
|
2001-04-26 |
2008-01-10 |
Amgen Mountain View Inc. |
Combinatorial libraries of monomer domains
|
|
US20030004561A1
(en)
|
2001-06-28 |
2003-01-02 |
Steve Bigus |
Peeling sheath for self-expanding stent
|
|
AU2002342672A1
(en)
|
2001-09-11 |
2003-03-24 |
Nascacell Gmbh |
Method for screening for inhibitors of protein/protein interaction and corresponding ribozymes
|
|
US20080193445A1
(en)
*
|
2002-01-18 |
2008-08-14 |
Liliane Goetsch |
Novel anti-IGF-IR antibodies and uses thereof
|
|
SG161101A1
(en)
|
2002-02-22 |
2010-05-27 |
Schering Corp |
Pharmaceutical formulations of antineoplastic agents, in particular temozolomide processes of making and using the same
|
|
EP1916001B1
(en)
|
2002-03-04 |
2011-05-25 |
Imclone LLC |
Human antibodies specific to KDR and uses thereof
|
|
AU2003243436A1
(en)
|
2002-06-06 |
2003-12-22 |
Shohei Koide |
Reconstituted polypeptides
|
|
CN102584997A
(zh)
|
2002-11-08 |
2012-07-18 |
埃博灵克斯股份有限公司 |
针对肿瘤坏死因子-α的单结构域抗体及其用途
|
|
US7053701B2
(en)
|
2003-11-04 |
2006-05-30 |
Vice Michael W |
Power amplifier output stage with multiple power states and improved efficiency
|
|
EP2302229B1
(en)
|
2003-11-17 |
2016-06-08 |
Telezygology Inc. |
Shape memory releasable fastening system
|
|
SG149004A1
(en)
*
|
2003-12-05 |
2009-01-29 |
Bristol Myers Squibb Co |
Inhibitors of type 2 vascular endothelial growth factor receptors
|
|
US20080220049A1
(en)
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
|
US20070059336A1
(en)
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
WO2005110374A1
(en)
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
|
US20060182783A1
(en)
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
JP2008512352A
(ja)
|
2004-07-17 |
2008-04-24 |
イムクローン システムズ インコーポレイティド |
新規な四価の二重特異性抗体
|
|
US7597884B2
(en)
*
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
BRPI0516308A2
(pt)
|
2004-10-04 |
2010-06-15 |
Qlt Usa Inc |
composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida
|
|
EP1838307A1
(en)
|
2004-12-02 |
2007-10-03 |
Schering Corporation |
Methods of using temozolomide formulation intrathecally in the treatment of cancers
|
|
BRPI0519897A2
(pt)
|
2005-02-23 |
2009-08-18 |
Merrimack Pharmaceuticals Inc |
método para modular a atividade ou atividades biológicas de moléculas alvo em uma célula alvo, agente de ligação biespecìfico, composição, uso de um agente de ligação biespecìfico, e, kit
|
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US7887273B2
(en)
|
2005-09-15 |
2011-02-15 |
Newfrey Llc |
Blind rivet and method
|
|
US20070072933A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an ocular agent
|
|
US8097438B2
(en)
*
|
2005-10-07 |
2012-01-17 |
The Regents Of The University Of California |
Nucleic acids encoding modified cytochrome P450 enzymes and methods of use thereof
|
|
CN101394834A
(zh)
|
2005-10-18 |
2009-03-25 |
阿勒根公司 |
用糖皮质激素衍生物选择性渗透后段组织来治疗眼睛
|
|
WO2007053807A2
(en)
|
2005-10-31 |
2007-05-10 |
Wisconsin Alumni Research Foundation |
Calcitriol for treating intraocular diseases associated with angiogenesis
|
|
EP1945767B1
(de)
|
2005-11-09 |
2010-04-07 |
MorphoSys AG |
Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
|
|
EP3269381B1
(en)
*
|
2005-11-23 |
2020-10-07 |
Acceleron Pharma, Inc. |
Activin-actriia antagonists in use for promoting bone growth
|
|
EP2397148A3
(en)
|
2006-02-02 |
2012-04-25 |
Allergan, Inc. |
Compositions and methods for the treatment of ophthalmic disease
|
|
JP5161796B2
(ja)
*
|
2006-02-24 |
2013-03-13 |
シエシー ファルマセウティチィ ソシエタ ペル アチオニ |
抗アミロイド免疫原性組成物、方法、および使用
|
|
EP2013229A2
(en)
*
|
2006-04-21 |
2009-01-14 |
Transgene S.A. |
Hpv-18-based papillomavirus vaccine
|
|
US20070269422A1
(en)
|
2006-05-17 |
2007-11-22 |
Ablynx N.V. |
Serum albumin binding proteins with long half-lives
|
|
JP5638804B2
(ja)
|
2006-08-04 |
2014-12-10 |
アストラゼネカ アクチボラグ |
ＥｒｂＢ２に対する抗体
|
|
WO2008031098A1
(en)
|
2006-09-09 |
2008-03-13 |
The University Of Chicago |
Binary amino acid libraries for fibronectin type iii polypeptide monobodies
|
|
WO2008048970A2
(en)
*
|
2006-10-16 |
2008-04-24 |
The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Synthetic antibodies
|
|
AU2007325838B2
(en)
|
2006-11-22 |
2013-09-19 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
|
|
US8476243B2
(en)
*
|
2006-12-29 |
2013-07-02 |
Transderm, Inc. |
Methods and compositions for treating keratin hyperproliferative disorders
|
|
ATE516814T1
(de)
|
2007-02-02 |
2011-08-15 |
Bristol Myers Squibb Co |
10fn3 domain zur behandlung von krankheiten begleitet von unerwünschter angiogenese
|
|
MX2009009379A
(es)
|
2007-03-02 |
2009-09-14 |
Amgen Inc |
Metodos y composiciones para tratar enfermedades tumorales.
|
|
US11078262B2
(en)
|
2007-04-30 |
2021-08-03 |
Allergan, Inc. |
High viscosity macromolecular compositions for treating ocular conditions
|
|
US8420779B2
(en)
|
2007-05-22 |
2013-04-16 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
|
US8680019B2
(en)
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
|
JP5781762B2
(ja)
|
2007-08-10 |
2015-09-24 |
プロテリックス、インク |
ユニバーサルｉｉｉ型フィブロネクチン結合ドメインのライブラリ
|
|
US20100285000A1
(en)
*
|
2007-08-20 |
2010-11-11 |
Bristol-Myers Squibb Company |
Use of vegfr-2 inhibitors for treating metastatic cancer
|
|
JP5496897B2
(ja)
|
2007-10-04 |
2014-05-21 |
ザイモジェネティクス， インコーポレイテッド |
Ｂ７ファミリーメンバーのｚＢ７Ｈ６ならびに関連する組成物および方法
|
|
ES2533874T3
(es)
|
2007-10-31 |
2015-04-15 |
Medimmune, Llc |
Armazón proteico
|
|
EP2217274A1
(en)
|
2007-11-28 |
2010-08-18 |
Bristol-Myers Squibb Company |
Combination vegfr2 therapy with mtor inhibitors
|
|
EP2238247A2
(en)
|
2007-12-19 |
2010-10-13 |
Centocor Ortho Biotech Inc. |
Alternative scaffold protein fusions phage display via fusion to plx of m13 phage
|
|
US20100322930A1
(en)
|
2007-12-27 |
2010-12-23 |
Frank Kolbinger |
Fibronectin-based binding molecules and their use
|
|
JP2011517314A
(ja)
|
2008-02-14 |
2011-06-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｅｇｆｒに結合する操作されたタンパク質に基づく標的化された治療薬
|
|
US9296810B2
(en)
|
2008-05-02 |
2016-03-29 |
Novartis Ag |
Fibronectin-based binding molecules and uses thereof
|
|
EP2799448A1
(en)
|
2008-05-22 |
2014-11-05 |
Bristol-Myers Squibb Company |
Multivalent fibronectin based scaffold domain proteins
|
|
MX2011004550A
(es)
|
2008-10-31 |
2011-07-20 |
Centocor Ortho Biotech Inc |
Composiciones de de supercóntigos a base de dominios de fibronectina tipo iii, métodos y usos.
|
|
US8415291B2
(en)
|
2008-10-31 |
2013-04-09 |
Centocor Ortho Biotech Inc. |
Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses
|
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
|
|
CN102245771B
(zh)
|
2008-12-16 |
2013-04-10 |
诺瓦提斯公司 |
酵母展示系统
|
|
US20100210511A1
(en)
*
|
2009-02-11 |
2010-08-19 |
Bristol-Myers Squibb Company |
Combination VEGFR2 Therapy with Temozolomide
|
|
AU2010213892B2
(en)
|
2009-02-12 |
2014-10-23 |
Janssen Biotech, Inc. |
Fibronectin type III domain based scaffold compositions, methods and uses
|
|
US8067201B2
(en)
*
|
2009-04-17 |
2011-11-29 |
Bristol-Myers Squibb Company |
Methods for protein refolding
|
|
US20120270797A1
(en)
|
2009-08-13 |
2012-10-25 |
Massachusetts Institute Of Technology |
Engineered proteins including mutant fibronectin domains
|
|
EP3434769B1
(en)
|
2009-10-30 |
2020-11-25 |
Novartis AG |
Universal fibronectin type iii bottom-side binding domain libraries
|
|
WO2011051466A1
(en)
|
2009-11-02 |
2011-05-05 |
Novartis Ag |
Anti-idiotypic fibronectin-based binding molecules and uses thereof
|
|
US20110123545A1
(en)
|
2009-11-24 |
2011-05-26 |
Bristol-Myers Squibb Company |
Combination of vegfr2 and igf1r inhibitors for the treatment of proliferative diseases
|
|
WO2011092233A1
(en)
|
2010-01-29 |
2011-08-04 |
Novartis Ag |
Yeast mating to produce high-affinity combinations of fibronectin-based binders
|
|
US8961977B2
(en)
|
2010-02-12 |
2015-02-24 |
University Of Rochester |
Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies
|
|
JP2013520426A
(ja)
|
2010-02-18 |
2013-06-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｉｌ−２３に結合する、フィブロネクチンをベースとする足場ドメインタンパク質
|
|
AU2011240620A1
(en)
|
2010-04-13 |
2012-10-18 |
Medimmune, Llc |
Fibronectin type III domain-based multimeric scaffolds
|
|
CN105175532B
(zh)
|
2010-04-13 |
2023-01-17 |
百时美施贵宝公司 |
结合pcsk9的基于纤连蛋白的支架域蛋白质
|
|
CA2797274C
(en)
|
2010-04-30 |
2024-01-23 |
Centocor Ortho Biotech Inc. |
Stabilized fibronectin domain compositions, methods and uses
|
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
|
WO2011150133A2
(en)
*
|
2010-05-26 |
2011-12-01 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins having improved stability
|
|
JP6092773B2
(ja)
|
2010-07-30 |
2017-03-08 |
ノバルティス アーゲー |
フィブロネクチンクレードル分子及びそのライブラリ
|
|
US9260496B2
(en)
|
2010-12-22 |
2016-02-16 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind IL-23
|
|
SMT201700025T1
(it)
|
2011-04-13 |
2017-03-08 |
Bristol Myers Squibb Co |
Proteine di fusione ad fc comprendenti nuovi raccordi o arrangiamenti
|
|
EP3318880B1
(en)
|
2011-05-17 |
2020-12-16 |
Bristol-Myers Squibb Company |
Improved methods for the selection of binding proteins
|
|
WO2012158678A1
(en)
|
2011-05-17 |
2012-11-22 |
Bristol-Myers Squibb Company |
Methods for maintaining pegylation of polypeptides
|
|
MX358827B
(es)
|
2011-09-27 |
2018-09-05 |
Janssen Biotech Inc |
Supercóntigos de proteína basados en repeticiones de fibronectina tipo iii con superficies de unión alternativas.
|